Statin use contributes to rise in lipid-lowering drug use in Denmark

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1313, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Failure to Continue Lipid-Lowering Drug Use Following the Withdrawal of Cerivastatin

By Mantel-Teeuwisse A.K.

Drug Safety, Vol. 27, Iss. 1, 2004-01 ,pp. : 63-70

Adis International

Access to resources Recommend Favorite

Drug Treatment of Hyperlipidaemia: A Guide to the Rational Use of Lipid-Lowering Drugs

By Toth Peter P.

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1363-1379

Adis International

Access to resources Recommend Favorite

Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision

By Trifirò G.

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 619-625

Springer Publishing Company

Access to resources Recommend Favorite

Early initiation of lipid-lowering therapy improves use in ACS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Lipid-lowering therapy use below par among Danish IHD patients

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 452, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite